Barclays Maintains Overweight Rating on Elevance Health
Barclays maintained an Overweight rating on Elevance Health, per Benzinga ratings actions.
Story updates
02:24:58 PM UTC
SquawkNews
Elevance Health Price Target Raised to $469.00/Share From $457.00 by Barclays
02:25:05 PM UTC
SquawkNews
Elevance Health Is Maintained at Overweight by Barclays